IDEAS home Printed from https://ideas.repec.org/a/eee/corfin/v86y2024ics0929119924000488.html
   My bibliography  Save this article

Opioid epidemic and corporate innovation

Author

Listed:
  • Chen, Chong
  • Huang, Qianqian
  • Shi, Chang
  • Yuan, Tao

Abstract

This paper examines the impact of the local opioid epidemic on corporate innovation. Utilizing a large sample of U.S. public firms from 2003 to 2017, we find that firms located in counties with higher death rates caused by opioid overdoses are significantly less innovative as measured by their patenting activities. To establish causality, we exploit the state implementations of the Prescription Drug Monitoring Programs (PDMPs) as quasi-experiments and an instrumented variable approach. We find suggestive evidence that the opioid epidemic hinders local firms' innovation by increasing healthcare costs, decreasing productivity, and through the exodus of local inventors.

Suggested Citation

  • Chen, Chong & Huang, Qianqian & Shi, Chang & Yuan, Tao, 2024. "Opioid epidemic and corporate innovation," Journal of Corporate Finance, Elsevier, vol. 86(C).
    • Handle: RePEc:eee:corfin:v:86:y:2024:i:c:s0929119924000488
    DOI: 10.1016/j.jcorpfin.2024.102586
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0929119924000488
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.jcorpfin.2024.102586?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Keywords

    Opioid crisis; Corporate innovation; Inventors; Productivity; Mobility;
    All these keywords.

    JEL classification:

    • G30 - Financial Economics - - Corporate Finance and Governance - - - General
    • G38 - Financial Economics - - Corporate Finance and Governance - - - Government Policy and Regulation
    • I10 - Health, Education, and Welfare - - Health - - - General
    • O30 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:corfin:v:86:y:2024:i:c:s0929119924000488. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/jcorpfin .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.